2012 - Member of Academia Europaea
2007 - Fellow of the Royal Society, United Kingdom
Member of the Association of American Physicians
Peter J. Barnes spends much of his time researching Immunology, Internal medicine, Asthma, COPD and Endocrinology. As a member of one scientific family, Peter J. Barnes mostly works in the field of Immunology, focusing on Sputum and, on occasion, Methacholine. His Internal medicine study frequently draws connections to adjacent fields such as Gastroenterology.
His Asthma research is multidisciplinary, incorporating elements of Corticosteroid and Anesthesia, Inhalation. His research in COPD intersects with topics in Oxidative stress, Respiratory disease, Lung, Pulmonary disease and Intensive care medicine. His studies deal with areas such as Bronchoconstriction, Receptor and Intensive care as well as Endocrinology.
Internal medicine, Immunology, Asthma, Endocrinology and COPD are his primary areas of study. His research investigates the link between Internal medicine and topics such as Gastroenterology that cross with problems in Exhaled breath condensate. His Immunology research integrates issues from Oxidative stress and Sputum.
His study in Asthma is interdisciplinary in nature, drawing from both Respiratory disease and Anesthesia, Inhalation, Airway. His studies in Anesthesia integrate themes in fields like Placebo and Bronchodilator. In his research on the topic of COPD, Disease is strongly related with Intensive care medicine.
Peter J. Barnes mainly investigates COPD, Immunology, Internal medicine, Inflammation and Oxidative stress. His COPD research is multidisciplinary, relying on both Intensive care medicine, Sputum, Lung, Asthma and Airway. His research integrates issues of Bronchoalveolar lavage and Macrophage in his study of Immunology.
He combines subjects such as Gastroenterology, Placebo, Endocrinology and Cardiology with his study of Internal medicine. His biological study spans a wide range of topics, including Pharmacology and p38 mitogen-activated protein kinases. His Oxidative stress study deals with Senescence intersecting with Cancer research.
His primary areas of study are Immunology, COPD, Inflammation, Internal medicine and Oxidative stress. Peter J. Barnes has included themes like Sputum, Disease and Bronchoalveolar lavage in his Immunology study. His COPD research is multidisciplinary, incorporating perspectives in Intensive care medicine, Lung, Asthma, Theophylline and p38 mitogen-activated protein kinases.
The concepts of his Asthma study are interwoven with issues in Clinical trial and MEDLINE. His Inflammation study incorporates themes from Airway obstruction and Parenchyma. The study incorporates disciplines such as Gastroenterology, Anesthesia, Inhalation and Endocrinology in addition to Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Jørgen Vestbo;Suzanne S. Hurd;Alvar G. Agustí;Paul W. Jones.
American Journal of Respiratory and Critical Care Medicine (2007)
Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.
Peter J. Barnes;Michael Karin.
The New England Journal of Medicine (1997)
Chronic obstructive pulmonary disease
Peter J. Barnes.
Global strategy for asthma management and prevention: GINA executive summary.
E D Bateman;S S Hurd;P J Barnes;J Bousquet.
European Respiratory Journal (2008)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Claus F. Vogelmeier;Gerard J. Criner;Fernando J. Martinez;Antonio Anzueto.
American Journal of Respiratory and Critical Care Medicine (2017)
Chronic obstructive pulmonary disease.
Peter J. Barnes;Peter G. J. Burney;Edwin K. Silverman;Bartolome R. Celli.
Nature Reviews Disease Primers (2015)
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
Margaret J Leckie;Anneke ten Brinke;Jamey Khan;Zuzana Diamant.
The Lancet (2000)
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group
Romain A. Pauwels;Claes-Göran Löfdahl;Dirkje S. Postma;Anne E. Tattersfield.
The New England Journal of Medicine (1997)
Systemic manifestations and comorbidities of COPD
P J Barnes;B R Celli.
European Respiratory Journal (2009)
Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
Vera M. Keatings;Paul D. Collins;Denise M. Scott;Peter J. Barnes.
American Journal of Respiratory and Critical Care Medicine (1996)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: